[1] |
Lee MS, Hsu CC, Wahlqvist ML, et al. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancerinc idences in Taiwanese: a representative population prospective cohort study of 800, 000 individuals [J]. BMC Cancer, 2011, 11: 20
|
[2] |
Nie Z, Zhu H, Gu M. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis [J]. Pharm Biol, 2016, 54(11): 2636-2642.
|
[3] |
de Kort S, Simons CC, van den Brandt PA, et al. Diabetes mellitustype 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer [J]. Eur J Gastroenterol Hepatol, 2016, 28(8): 896-903.
|
[4] |
Coyle C, Cafferty FH, Vale C, et al. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J]. Ann Oncol, 2016, 27(12): 2184-2195.
|
[5] |
Zakikhani M, Dowling RJ, Sonenberg N, et al. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase [J]. Cancer Prev Res(Phila), 2008, 1(5): 369-375.
|
[6] |
Tomimoto A, Endo H, Sugiyama M, et al. Metformin suppresses intestinal polyp growth in ApcMin/+ mice [J]. Cancer Sci, 2008, 99(11): 2136-2141.
|
[7] |
朱智峰,梁琳琅. 二甲双胍对结肠癌细胞增殖、周期及凋亡的影响 [J]. 中国医科大学学报, 2012, 41(2): 115-119.
|
[8] |
郭娜,逢曙光. 二甲双胍抑制晚期糖基化终产物诱导的大肠癌细胞侵袭和上皮间质转化 [J]. 中国老年学杂志, 2015, 35(19): 5374-5377.
|
[9] |
Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J]. Oncogene, 2008, 27(25): 3576-3586.
|
[10] |
王静璐,史惠蓉,谢娅, 等.二甲双胍对不同分化程度的子宫内膜癌细胞增殖的影响及相关作用机制 [J]. 中华妇产科杂志, 2015, 65(9): 685-691.
|
[11] |
Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis [J]. Mol Oncol, 2017, 11(1): 28-39.
|
[12] |
Valaee S, Yaghoobi MM, Shamsara M. Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner [J]. PLoS One, 2017, 12(3): e0174486.
|
[13] |
Zhao Z, Cheng X, Wang Y, et al. Metformin inhibits theIL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis [J]. PLoS One, 2014, 9(4): e95884.
|